Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Adults with certain skin conditions may have higher levels of inflammation in their body.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

SLE and DM can coexist but are rare and need careful evaluation.

Dianabol boosts muscle growth but has serious health risks and legal issues.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Human skin can make serotonin and melatonin.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Minoxidil, finasteride, and low-level laser light therapy effectively treat hair loss.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Certain hormone treatments can improve acne and related conditions in women.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.